Continuum Advisory LLC Sells 112 Shares of Danaher Co. (NYSE:DHR)

Continuum Advisory LLC cut its holdings in shares of Danaher Co. (NYSE:DHRGet Rating) by 3.9% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 2,729 shares of the conglomerate’s stock after selling 112 shares during the quarter. Continuum Advisory LLC’s holdings in Danaher were worth $898,000 as of its most recent SEC filing.

Other hedge funds have also bought and sold shares of the company. Maryland Capital Advisors Inc. acquired a new position in shares of Danaher during the 4th quarter worth approximately $28,000. Dixon Hughes Goodman Wealth Advisors LLC acquired a new position in Danaher in the 4th quarter valued at $29,000. Lee Financial Co acquired a new position in Danaher in the 4th quarter valued at $30,000. Evolution Advisers Inc. acquired a new position in Danaher in the 4th quarter valued at $32,000. Finally, Dark Forest Capital Management LP acquired a new position in Danaher in the 3rd quarter valued at $33,000. 78.42% of the stock is currently owned by institutional investors and hedge funds.

Several research firms have recently issued reports on DHR. StockNews.com lowered Danaher from a “buy” rating to a “hold” rating in a report on Friday, April 22nd. UBS Group dropped their target price on Danaher from $365.00 to $340.00 in a research report on Sunday, April 24th. Robert W. Baird dropped their target price on Danaher from $334.00 to $319.00 and set an “outperform” rating for the company in a research report on Friday, April 22nd. Zacks Investment Research downgraded Danaher from a “buy” rating to a “hold” rating and set a $278.00 target price for the company. in a research report on Monday, April 25th. Finally, William Blair reiterated an “outperform” rating on shares of Danaher in a research report on Friday, April 22nd. Four research analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the stock. According to data from MarketBeat.com, Danaher currently has a consensus rating of “Buy” and an average price target of $331.14.

Shares of NYSE DHR opened at $266.49 on Friday. The firm has a market cap of $193.76 billion, a PE ratio of 30.84, a P/E/G ratio of 2.77 and a beta of 0.84. Danaher Co. has a 12-month low of $233.71 and a 12-month high of $333.96. The company’s fifty day simple moving average is $268.14 and its 200 day simple moving average is $285.79. The company has a quick ratio of 1.27, a current ratio of 1.68 and a debt-to-equity ratio of 0.51.

Danaher (NYSE:DHRGet Rating) last issued its earnings results on Thursday, April 21st. The conglomerate reported $2.76 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.65 by $0.11. The business had revenue of $7.69 billion for the quarter, compared to analyst estimates of $7.53 billion. Danaher had a net margin of 21.32% and a return on equity of 18.64%. Danaher’s revenue was up 11.6% on a year-over-year basis. During the same period in the prior year, the firm earned $2.52 earnings per share. On average, equities analysts predict that Danaher Co. will post 10.31 earnings per share for the current year.

The business also recently announced a quarterly dividend, which will be paid on Friday, July 29th. Investors of record on Friday, June 24th will be paid a dividend of $0.25 per share. This represents a $1.00 annualized dividend and a yield of 0.38%. The ex-dividend date of this dividend is Thursday, June 23rd. Danaher’s dividend payout ratio is presently 11.57%.

In other Danaher news, EVP Joakim Weidemanis sold 6,500 shares of the company’s stock in a transaction on Monday, April 25th. The shares were sold at an average price of $255.74, for a total transaction of $1,662,310.00. Following the transaction, the executive vice president now owns 86,398 shares in the company, valued at $22,095,424.52. The transaction was disclosed in a filing with the SEC, which is accessible through this link. 11.20% of the stock is owned by corporate insiders.

Danaher Profile (Get Rating)

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization; microscopes; genomics consumables; and Gene and Cell Therapy.

See Also

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.